ERCC2 and breast carcinoma: Although several studies have individually explored the roles of XRCC1 (rs1799782), CHEK2 (rs17879961), and XPD (rs238406) in cancer risk, few have evaluated their combined interaction or distribution across breast cancer subtypes in a clinically annotated patient population.